These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 7186430)

  • 1. Transfusion-transmitted viral hepatitis.
    Mosley JW
    Clin Lab Med; 1982 Mar; 2(1):233-52. PubMed ID: 7186430
    [No Abstract]   [Full Text] [Related]  

  • 2. Post-transfusion hepatitis: analysis of risk factors.
    Aach RD; Hollinger FB; Szmuness W; Mosley JW; Gitnick GL; Kahn RA; Stevens CE; Goodwin D; Weiner JM
    Acta Haematol Pol; 1980; 11(3):159-64. PubMed ID: 6778053
    [No Abstract]   [Full Text] [Related]  

  • 3. Donor serum alanine aminotransferase activity and the risk of transfusion-associated hepatitis.
    Lenes BA; Tomasulo P; Alter HJ; Holland PV
    N Engl J Med; 1983 Mar; 308(12):723. PubMed ID: 6402702
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of donors in the spread of viral hepatitis].
    Grinshtein EA; Aleinik MD; Altman RSh; Klimova NIa; Piskunova AV
    Sov Med; 1973 Mar; 36(3):129-32. PubMed ID: 4756447
    [No Abstract]   [Full Text] [Related]  

  • 5. New concepts in viral hepatitis.
    Soltis RD
    Geriatrics; 1981 Jun; 36(6):62-7, 70. PubMed ID: 7227821
    [No Abstract]   [Full Text] [Related]  

  • 6. [Post-transfusion hepatitis and the diagnosis of infectious hepatitis in donors (a review of the literature and the authors' own data)].
    Gromashevskaia LL; Khersonskaia RIa; Stroganov BV
    Probl Gematol Pereliv Krovi; 1973 Feb; 18(2):40-5. PubMed ID: 4587776
    [No Abstract]   [Full Text] [Related]  

  • 7. Prophylaxis and prevention of viral hepatitis.
    Luk GD; Bynum TE
    Johns Hopkins Med J; 1979 Apr; 144(4):127-34. PubMed ID: 86636
    [No Abstract]   [Full Text] [Related]  

  • 8. Post-transfusion hepatitis and serum alanine aminotransferase in blood donors.
    N Engl J Med; 1981 Aug; 305(7):403-4. PubMed ID: 6789203
    [No Abstract]   [Full Text] [Related]  

  • 9. [Currently available means for the prevention of post-transfusion hepatitis and criteria for their application].
    Bedarida G; Cambiè G; D'Agostino F; Sterza G
    Ric Clin Lab; 1984; 14 Suppl 1():37-60. PubMed ID: 6429830
    [No Abstract]   [Full Text] [Related]  

  • 10. [Screening of blood donors for the prevention of non-A, non-B hepatitis].
    Seidl S
    Dtsch Med Wochenschr; 1983 Jan; 108(4):123-4. PubMed ID: 6402351
    [No Abstract]   [Full Text] [Related]  

  • 11. [GPT limit values in blood donors: lower, higher or eliminate completely?].
    Caspari G; Gerlich WH
    Infusionsther Transfusionsmed; 1995 Jun; 22(3):142-4. PubMed ID: 7640508
    [No Abstract]   [Full Text] [Related]  

  • 12. Based on your analysis of the benefits and costs of routine donor screening for ALT-GPT to reduce the incidence of post-transfusion non-A, non-B hepatitis in your blood services region, what action would you recommend on this matter?
    Vox Sang; 1983; 44(1):48-64. PubMed ID: 6402857
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis-associated antigen (Australia antigen) in Massachusetts blood donors.
    Kliman A; Reid NR; Lilly C; Morrison J
    N Engl J Med; 1971 Sep; 285(14):783-5. PubMed ID: 5567264
    [No Abstract]   [Full Text] [Related]  

  • 14. The dominant role of non-A, non-B in the pathogenesis of post-transfusion hepatitis: a clinical assessment.
    Alter HJ
    Clin Gastroenterol; 1980 Jan; 9(1):155-70. PubMed ID: 6772362
    [No Abstract]   [Full Text] [Related]  

  • 15. [Transmission of hepatitis by transfusion].
    Fiser-Herman M; Polak A
    Lijec Vjesn; 1970; 92(5):545-53. PubMed ID: 5205536
    [No Abstract]   [Full Text] [Related]  

  • 16. [Virus and the liver -- pathogenesis of viral hepatitis].
    Deinhardt F
    Verh Dtsch Ges Pathol; 1981; 65():57-71. PubMed ID: 6812302
    [No Abstract]   [Full Text] [Related]  

  • 17. [Contribution to the task of reducing the incidence of post transfusion non-A, non-B hepatitis].
    Hernández Sánchez MC; Vila Enriquez P; Alvarez Hernández M
    Sangre (Barc); 1989 Jun; 34(3):248-9. PubMed ID: 2503897
    [No Abstract]   [Full Text] [Related]  

  • 18. Reducing hepatitis by testing blood for alanine aminotransferase.
    Kahn RA
    N Engl J Med; 1983 Apr; 308(14):844-5. PubMed ID: 6403860
    [No Abstract]   [Full Text] [Related]  

  • 19. [Post-transfusion hepatitis].
    Fiedler H
    Dtsch Med Wochenschr; 1989 Jul; 114(27):1090-1. PubMed ID: 2500321
    [No Abstract]   [Full Text] [Related]  

  • 20. SEN virus infection and its relationship to transfusion-associated hepatitis.
    Umemura T; Yeo AE; Sottini A; Moratto D; Tanaka Y; Wang RY; Shih JW; Donahue P; Primi D; Alter HJ
    Hepatology; 2001 May; 33(5):1303-11. PubMed ID: 11343260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.